Epithelioid Sarcoma Responds to the Oral EZH2 Inhibitor Tazemetostat

Authors:

Published: 2020-10-16

DOI: 10.1158/2159-8290.cd-rw2020-151

Source: Full article

---

Abstract

Abstract